1,394
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs

, , , , , & ORCID Icon show all
Article: 2247303 | Received 20 Apr 2023, Accepted 09 Aug 2023, Published online: 13 Aug 2023